Macrogen, Inc. (KOSDAQ:038290)
South Korea · Delayed Price · Currency is KRW 11,970
-320 (-2.60%)
Jun 30, 2026, 3:30 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 129.77 billion as of June 30, 2026. Its market cap has decreased by -23.95% in one year.
Market Cap
129.77B
Enterprise Value
182.72B
Revenue
199.60B
Ranking
n/a
PE Ratio
34.08
Stock Price
11,970.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has decreased from 148.29B to 129.77B, a decrease of -12.49%. That is a compound annual growth rate of -0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 129.77B | -29.05% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EASY BIO,Inc. | 207.42B |
| Anterogen.Co.,Ltd. | 207.13B |
| Helixmith | 192.48B |
| Bioneer | 181.70B |
| JETEMA, | 181.22B |
| NeoImmuneTech | 130.80B |
| Genexine | 120.52B |
| Vaxcell-Bio Therapeutics | 119.54B |